Budesonide — A New Steroid for Intranasal Use
- 1 August 1981
- Vol. 36 (6) , 425-428
- https://doi.org/10.1111/j.1398-9995.1981.tb01849.x
Abstract
Patients (29) with seasonal rhinitis completed a doube-blind study comparing budesonide nasal spray 200 .mu.g b.i.d. [twice daily] with placebo. The patients were randomly assigned ito 2 parallel groups. Symptoms were assessed over a treatment period of 3 wk. There were statistically significant differences in favor of budesonide on all measurements. Side effects were mild and the incidence was low.Keywords
This publication has 6 references indexed in Scilit:
- Treatment of ragweed hay fever with an intranasal spray containing flunisolide, a new synthetic corticosteroidJournal of Allergy and Clinical Immunology, 1976
- Local Effect of Intranasal Beclomethasone Dipropionate Aerosol in Hay FeverBMJ, 1973
- Effect of intranasal betamethasone-17-valerate on allergic rhinitis and adrenal functionJournal of Allergy, 1969
- Adrenal function during the use of dexamethasone aerosols in the treatment of ragweed hay feverJournal of Allergy, 1967
- Suppression of hay fever symptoms with intranasal dexamethasone aerosolJournal of Allergy, 1965
- TREATMENT OF HAY-FEVER WITH HYDROCORTISONE SNUFFThe Lancet, 1956